Clinical Trial Update: A Randomized Phase 3 Trial of Pemetrexed and Cisplatin Versus Gemcitabine and Cisplatin in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial comparing pemetrexed plus cisplatin versus gemcitabine plus cisplatin in locally advanced or metastatic non-small cell lung cancer ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Carcinoma

Drugs mentioned

• CISPLATIN (cisplatin)
• Gemcitabine (Gemcitabine)
• Pemetrexed (pemetrexed)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Non Small Cell Lung Carcinoma | Phase 3 | Status: COMPLETED